Fractyl Health (GUTS) Return on Equity (2023 - 2025)
Fractyl Health (GUTS) has disclosed Return on Equity for 3 consecutive years, with 9.08% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Equity rose 1036.0% year-over-year to 9.08%, compared with a TTM value of 9.08% through Sep 2025, up 1036.0%, and an annual FY2024 reading of 0.6%, changed N/A over the prior year.
- Return on Equity was 9.08% for Q3 2025 at Fractyl Health, down from 16.46% in the prior quarter.
- Across five years, Return on Equity topped out at 16.46% in Q2 2025 and bottomed at 5.36% in Q1 2025.
- Average Return on Equity over 3 years is 2.05%, with a median of 0.36% recorded in 2023.
- Peak annual rise in Return on Equity hit 1734bps in 2025, while the deepest fall reached -584bps in 2025.
- Year by year, Return on Equity stood at 0.16% in 2023, then crashed by -1548bps to 2.27% in 2024, then surged by 500bps to 9.08% in 2025.
- Business Quant data shows Return on Equity for GUTS at 9.08% in Q3 2025, 16.46% in Q2 2025, and 5.36% in Q1 2025.